Categoria: Indian Generic Price

For method development, method validation, and degradation sample analysis, an Agilent high-performance liquid chromatography Infinity 1260-II (Agilent Technologies company, Santa Clara, CA, USA) equipped with a quaternary pump, an online degasser, and a multiple wavelength or diode array ultraviolet detector was used. For data acquisition and processing, the OpenLabTM CDS software (version 2.6) (Agilent Technologies, Palo Alto, CA, USA) was used. Indian drugmaker Intas was making cancer drugs for the United States at the plant where, in a trash bin, inspectors found documents doused in acetic acid.

India’s Solution To Drug Costs: Ignore Patents And Control Prices – Except For Home Grown Drugs

Thus, the Indian government should establish ongoing support to small- and medium-sized Indian companies in training and implementing FDA standards, as it provides easy global access to those and similar international markets. India has witnessed rapid population and economic growth in the past two decades, and this expansion has created a demand for larger and better infrastructure in cities and industrial parks. India’s limited development of service platforms is a result of the scarce functioning of the bureaucracy, but conditions have improved in recent years. There is a need to reserve appropriate sizes of land for the health-care sector in cities and for pharmaceutical companies in industrial belts during the planning process. In India, the public health-care system is not strong, and most of the middle class and above prefer to visit private hospitals for treatment.

The Same Pill That Costs $1,000 in America Sells for $4 in India

The current regulations are not yet designed to promote patent filings (Chaudhuri, 2019), and this situation strongly impacts the internationalization perspective. The Indian pharmaceutical industry is among the top producers in the world, supplying over 50% of the global demand for various vaccines, 40% of generic demand in the USA and 25% of all medicines in the UK (IBEF, 2020). Although the sector still shows more relevant values concerning production quantity than production turnover, pharmaceutical exports are expected to reach US$16.28bn in FY20 (ibidem).

A narrative strengths, weaknesses, opportunities and threats analysis of the Indian pharmaceutical industry

Therefore, it will be crucial to see the direction in which the pharmaceutical pricing policy of India is moving. Fluctuations in input costs (raw materials, manufacturing equipment, etc.) and inflationary pressures, which are unpredictable and beyond the purview of control of pharmaceutical companies, also pose a hurdle to the determination of price fixation of non-essential medicines. As a result, manufacturers often find it difficult to recuperate costs of research and development and costs of innovation. Drug pricing and reimbursement within India are shaped by a complex interplay of regulatory, economic and policy factors. The aim is to adopt a balanced approach that considers the needs of the patients, while simultaneously ensuring the creation of a sustainable healthcare system and incentivisation for pharmaceutical companies to innovate and create value. In this endeavour, the Government continuously evaluates and reforms existing policies relating to pharmaceutical pricing and reimbursement.

New moves in science: addressing the unmet needs of Inflammatory Bowel Disease patients

• To make quality generic medicine affordable, India’s People’s Medicine Scheme (Jan Aushadhi) was launched in 2008 and then revamped and rebranded as Pradhan Mantri Bhartiya Jan Ausadhi Pariyojana (PMBJP) in 2015.
• Making the healthcare supply chain resilient will require end-to-end supply chain visibility through digitalisation and use of global standards which facilitate interoperability.
• For instance, if availability of 7 (N) antimicrobials medicines in 02 PMBJP pharmacies (P) at PHC level in Palghar was evaluated, then overall 14 units (PXN) would be examined.
• Ask your doctor to write a prescription allowing the pharmacist to substitute a generic drug when it’s appropriate.
• In addition to litigation, the firm advises clients on representations to be made to governmental regulatory bodies like the NPPA.
• One reason could be that the country’s pharmaceutical price controls measures generally disincentivise pharma companies from developing novel originator medicines while incentivising the production of generics.

Ask your doctor to write a prescription allowing the pharmacist to substitute a generic drug when it’s appropriate. PTR is the price at which wholesaler (distributor) sells the product to the retailer and the bill (voucher) given to retailer by wholesaler mentions the PTR. This price was checked and confirmed from Form V (under DPCO, 1995) available at the distributors of the company. It is mandatory for all the companies to give Form V that gives details of the product with MRP, PTR, taxes paid, etc to their distributors. Qualified standards of AMLO besylate were purchased from Sigma-Aldrich (Bangalore, India). For the experiment purpose, nine top-selling AMLO containing FPPs were purchased from local pharmacy outlets in Guwahati (Assam, India).

CONVERGENCE OF NATIONAL HEALTH PROGRAMMES

In addition, views of healthcare professionals regarding unbranded generic medicine were studied. PMBJP, originally called Jan Aushadhi Scheme (JAS), was initiated by the United Progressive Alliance (UPA) Government in 2008. JAS, as is argued, Abiraterone price philippines is an important government intervention in the pharmaceutical market which would make the supply side effective particularly for consumers who are relatively responsive to price changes in making their purchasing decisions of medicines [15].

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference

In India, many pharmaceutical companies manufacture two types of products for the same molecule, i.e. the branded product which they advertise and push through doctors and branded-generic which they expect retailers to push in the market. The so-called branded medicines in India are manufactured and promoted by multinationals or by reputed Indian manufacturers. Branded-generics, on the other hand, are not promoted or advertized by the manufacturer. Patients’ and doctors’ perception for all branded-generics irrespective of company is the same. The Common Review Missions serve as a platform to not only highlight various state level experiences but also signal the way forward to overcome systemic challenges in access to essential medicines.

A Cost Analysis of the Jan Aushadhi Scheme in India

This study aims to access, analyze and highlight opportunities and problems of the Indian pharmaceutical sector in the broader national health-care industry. The recent changes in the field, at the institutional and corporate levels, have placed India in the spotlight of the global pharmaceutical market, but several threats and weaknesses could limit this expansion. It stands to reason that when the media raises concerns about the safety and scope of imported generic medicines, consumers question the quality of medicines essential to their health. These concerns raise fears among patients that taking drugs made in India may result in unpredictable effects.

“We spend a lot of time at work; we should enjoy it.”

Palbociclib is a targeted or biological therapy drug, that is USFDA, EMA, and CDSCO approved. Paleno, which contains Palbociclib is a medicine used to treat breast cancer treatment. Baladol, developed by PNB Vesper Life Sciences, has become the first new drug for treating COVID to enter phase II clinical trials around the world. Studies so far have shown that it reduces death rates by 80% – whereas WHO-approved medication dexamethasone reduces them by 20%.

PREVALENT STATE MECHANISMS FOR PROCUREMENT OF MEDICINES

A sample list of generic drugs available in India along with their indication is depicted in Table 1. Adequate infrastructure is one of the prerequisites for efficient storage and distribution of medicines. Progress in the direction of infrastructure expansion and strengthening improves both service delivery and availability of medicines for the end-users. When faced with challenges of infrastructural shortfall to store and dispense medicines, a few states reported adopting alternative measures to ensure the distribution of medicines. For instance, there were reports of users facing constraints in accessing medicines at these pharmacies due to stock out of generic medicines and distribution of near-expiry or expired medicines and branded medicines, which invariably resulted in OOPE.

Generic drug

This transformation has enabled the implementation of on-demand delivery models, employing strategies like direct-to-patient approaches and B2B eCommerce platforms. In fact, Indian pharmaceutical companies are now also becoming a key source of medicine for the rest of the developing world. Of note, they are playing a pivotal role in bringing down the price of lifesaving, antiretroviral drugs that have helped contain the AIDS epidemic.

• Aside from collecting primary data, secondary data such as the price information of some PMBJP medicines and their leading brand name counterparts (in terms of market share) were gathered from the web portals of PMBJP and MedGuideIndia.com respectively.
• A bottle of 21 capsules costs between 5000 and 6000 Indian Rupees, depending on the strength of the medicine, making it very affordable.
• Moving forward requires investing in modern, technology-enabled logistics facilities and ensuring the highest standards of quality in drug storage and handling.
• However, this year’s price increase is so marginal as to be almost equivalent to zero, especially compared to the significantly higher price increases observed in the last three years.
• By doing so, the brand has presented a cost-effective treatment for many patients of (HR+) (HER2-) advanced or metastatic breast cancer patients.
• Five commonly used medicines from different classes were selected whose branded (popular brand) and branded-generic versions were manufactured by the same pharmaceutical company.
• In most of the states, free medicines were restricted to targeted beneficiaries like BPL families, beneficiaries of JSSK, Janani Suraksha Yojana (JSY), and enrollees of state-specific insurance schemes.
• However, it must be noted that Novartis provides Glivec free of charge to 16,000 patients in India, roughly 95% of those who need it via the Novartis “Glivec International Patient Assistance Program”.

The regulatory framework in India for pharmaceutical pricing and reimbursement aims to ensure fair pricing of essential drugs and provision of adequate reimbursement mechanisms to facilitate patient access and simultaneously also promote innovation and enhancement of production capacity of healthcare providers. Lack of access to essential medicines is a major health policy concern globally, even more so in the low-and middle-income countries. According to the World Health Organisation, a whopping 2 billion people worldwide are not having access to essential medicines [1].

Making the case for Indian generic drug manufacturing

India’s share of the US generic market is growing rapidly, and the number of companies and manufacturing facilities supplying to the U.S. market is growing fast. The focus on growing regulatory requirements, improved healthcare infrastructure, and surge in research and development spend bodes well for the pharma industry. The Indian government believes that the prices of lifesaving drugs shouldn’t be set by market forces. In a country where very few people have health insurance, 70% of Indians pay for healthcare expenses out of their own pockets. There is no way that people in India can pay even a fraction of the cost for drugs that can be priced at $50,000/year in the West. The process of securing reimbursement for a pharmaceutical product varies and depends entirely on the specific processes provided under the respective policy.

Five Years into the Product Patent Regime: India’s Response

In the home market, drug prices are controlled by the drug price control order; therefore, there is strong pressure on revenues and subsequently on costs. In the international market, threats derived from pharmaceutical multinational companies are emerging as tough obstacles to overcome. Indian generic manufacturers are also producing in the U.S. and in other countries whenever necessary.

As such, pharmaceutical companies are permitted to increase the prices of their drugs by this percentage. The marginal price adjustment is expected to affect 923 scheduled formulations listed in the NLEM, including antibiotics, cardiovascular medicines, tuberculosis drugs, and Parkinson’s and dementia medicines, among others; the small scale of the adjustment renders it meaningless compared to previous price adjustments. However, it instead tipped the balance in favor of the pharmaceutical industry’s commercial interests, and away from access to affordable medicines. For example, the development of a range of long-acting HIV prevention and treatment medicines could be transformative in advancing the end of AIDS — but this can only happen if those medicines are made widely available at low prices through large-scale generic production. India has long been known as the “pharmacy of the world,” producing generic medicines at prices that other developing countries and global institutions can afford. The country was the single largest supplier of pharmaceutical products to Africa in 2018, and accounted for a fifth of the continent’s pharmaceutical imports.

In the above, API stands for Active Pharmaceutical Ingredient and AYUSH stands for Ayurveda, Yoga, Unani, Siddha and Homeopathy. Starting in 2014 in India, a Ministry of AYUSH was established, indicating the extraordinary relevance in the country of these specific items. More focus on patents for innovative drugs is required, instead of concentrating primarily on generic drugs. There is a need for policymakers to work on the sustainability and development of the industry, while the companies must redesign their orientation toward enhancing innovation capabilities. In addition, at the level of corporate strategy, firms should establish collaborations and alliances and expand their industrial marketing vision.

His efforts not only involved appointing and nurturing new business partners but also elevating sales to unprecedented levels, setting new benchmarks for success. His dynamic leadership led the Zota Health Care Limited to become a major player in Pharma Industry. He is entrusted with the responsibilities of looking after the planning and implementing new marketing strategies and projects of the Company.

Investments and Recent Developments

Earning a spot among the Top 200 Companies with Global Business Potential underscores a strong commitment to excellence, remarkable growth, and a significant impact on international markets. Akums has partnered with Caregen to introduce an innovative range of nutraceuticals and cosmeceuticals in India, aiming to revolutionize health and skincare solutions in the market. Akums Drugs has partnered with Jagdale Industries for the marketing and distribution of enzalutamide price in singapore ready-to-drink nutritional beverages, expanding its portfolio in the health and wellness segment. I would like to appreciate all the efforts taken by team Akums for delivering for delivering our first new product on time. We are glad to inform you that delivery performance for AIL TP products has been 100%. “Switching from traditional monthly planning cycles to real-time, weekly updates enables companies to respond swiftly to market changes,” Datta said.

• Piyush Nahar, an analyst with Jefferies India Private Ltd, said Indian drugmakers have increased their investment in compliance and some are considering investing in US or European plants to overcome regulatory challenges.
• You should only assume a drug is the same by looking at it; making a decision requires knowing the active ingredient composition.
• India is the largest provider of generic drugs globally and is known for its affordable vaccines and generic medications.
• There are 500 Active Pharmaceutical Ingredient (API) manufacturers contributing about 8% in the global API Industry.
• On the orange earnings per share line, the circles plot the sum of the trailing 4-quarters earnings.
• We are a purpose-driven business on a mission to end unaffordability in the healthcare sector of India.

Can I directly buy the alternative medicine that you have suggested?

• According to the recent report, revenues were $9.8 billion, and more than $9 billion in sales and purchased the rights to Allergan’s generics division in 2018.
• India hosts some of the world’s largest pharmaceutical companies known for their robust reputation in mass-producing generic medications.
• Numerous businesses manufacture generic birth control pills under various brand names.
• Antila Generic Medicine Private Limited is a pharmaceutical company established on 23rd February 2021.
• Pharmacists are knowledgeable about drugs and can easily help you identify whether a medicine is generic or brand-name based on its name and packaging.
• Ans 3.) From the sources of web and market reputation following are the companies eligible on the list.
• Illegitimate drugs have been a challenging issue for India over quite a period of time.

The Pharma sector currently contributes to around 1.72% of the country’s GDP. Because of the high pricing of branded medicines generic drugs are introduced. A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, kinetics, way of administration, quality, and intended use. The development of new drugs is protected by patents, which typically last for 20 years after approval. However, developing and marketing the branded medication might take a long time.

REITs and InvITs: Mobilizing Trillions for Infrastructure Development

The conducted studies show that both branded and generic medicines are bio-equivalent. The authority also confirmed that the generic medicines have the same amount of pharmaceutical ingredients and adhere to the manufacturing practices requirement but differ in size, color and shape. Medkart operates 100+ stores offering a variety of generic medicines at discounted prices, allowing customers to save money on their medications. In addition, the stores provide personalized advice from qualified pharmacists, who help customers choose the right generic medication for their needs. The Indian pharma companies have formed a brand popularity culture in the pharmaceutical industry. Earlier, the government of India proposed to colour code the medicines of little importance in identifying medicinal products and maintaining generic medicinal products on different shelves.

Nutra Healthcare Private Limited

Indian pharma companies have a substantial share in the prescription market in the US and EU. Zeelab Pharmacy specializes in providing you with affordable medicines online at the comfort of your home. This saves you all the hassles of stepping-out of your home, visiting a pharmacy and waiting in the queue to buy the prescribed medicine. We at Zeelab Pharmacy understand that sometimes you need medicines on an urgent-basis and that is the reason why we ensure that you receive your medication at the earliest possible. Akums proudly unveils its 20th Anniversary Campaign, ‘BHAROSA – Two Decades of Trust, Going Strong’, celebrating a legacy of reliability, sustainability, and innovation in pharmaceutical manufacturing. If you know of any generic medicine shop that is not listed on the above link, you can share with us their name and address by leaving a comment at the end of this article.

• Investment worth Rs 3,651 crore has already been grounded, till December 2023, by the scheme participants.
• The pharmaceutical generics sector, heavily reliant on Chinese supply chains, is expected to be most affected.
• The company offers a comprehensive range of speciality branded generic products catering to various chronic and acute therapies.
• A few years ago, while inaugurating a private hospital in Rajasthan, Prime Minister Narendra Modi announced that prescribing medicines in generic names shall be mandatory for all medical practitioners.
• India is home to more than 3,000 pharma companies with a strong network of over 10,500 manufacturing facilities as well as a highly skilled resource pool.
• With this trend coming up Davaindia introduced a new initiative of COCO (company owned company operated) store format initiated in Apr 2021 in Surat.
• However, seeing your doctor before filling out your medication list helps ensure you receive the correct medication.
• The Indian Pharmaceutical space is witnessing a storm of new start-ups, not only for cash flow opportunities the sector offers but also championing the cause of making medicines affordable for the needy.

Indian companies eye new trade channels in US amid erosion of generic prices

This means max gains for the customer and retailer, availability of all items and prompt response and above all transparency as you are connect with the company directly without any intermediate. India’s medical technology exports could reach US$ 20 billion (Rs. 1,69,000) by FY30, but the sector needs expanded government incentives and improved ease of doing business, says the CII. India’s FDI surged 45% to US$ 29.79 billion in H124, driven by strong inflows in services, technology, and pharmaceuticals sector. Akums has unveiled a new generic formulation for migraine treatment, offering an innovative and cost-effective option for patients.

Overview of Best Pharma Stocks in India as per Analyst Ratings

Our expertise ensures products that meet market trends and consumer expectations for skin health and beauty. Akums Drugs excels in API manufacturing, ensuring stringent quality control and adherence to global standards. Our APIs are crafted with precision and purity, supporting the pharmaceutical industry’s need for reliable and consistent ingredients.

What is Davaindia Generic Pharmacy?

The popularity of generic drugs among patients has increased tremendously as a result of their affordability and therapeutic benefits. Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is a campaign launched by the Department of Pharmaceuticals to provide quality medicines at affordable prices to the masses. PMBJP stores have been set up to provide generic drugs, which are available at lesser prices but are equivalent in quality and efficacy as expensive branded drugs. The Indian pharmaceutical industry ranks third globally in terms of production volume and has seen remarkable growth with a CAGR of 9.43% over the past nine years. India also stands as the largest provider of generic drugs worldwide, with pharmaceutical exports surpassing $25 billion in the fiscal year 2023.

How is the quality, safety and efficacy of medicines ensured?

Also the Co-Branded Khadi India products are exclusively available at Davaindia stores giving access to the premium products again at an affordable price. The petition argues that healthcare professionals prescribing generic drugs could help ease the financial burden on patients and improve access to essential medications. Since brand-name medicine development and marketing expenses are not included in the product price, generic medications are less expensive. New drugs will include the research, development, patent, marketing, and selling costs.

What is mean by Patent?

There are plenty of generic medical stores online where you can get popular generic drugs. Dr. Arunish Chawla, Secretary; Dept. of Pharmaceuticals gave a detailed presentation on the PLI scheme of the Union Government. He said that the drug and pharmaceutical industry in India witnessed a 12% compound annual growth rate (CAGR) in the last 10 years.

NEWS ANNOUNCEMENT

For Indian Contract Development and Manufacturing Organisations (CDMOs), the Biosecure Act offers an opportunity to strengthen their role as alternative suppliers in the global pharmaceutical market. While Indian CDMOs already play a significant role in generic drug production, the Act could allow them to expand into biologics and other advanced formulations required by the US market. However, the seven-year period also poses challenges, demanding proactive investment in capacity building, compliance with US regulatory standards, and strengthening supply chains. The proposed tariff hike by the US on Chinese goods, potentially rising to 60%, could alter global trade dynamics, particularly in the pharmaceutical sector, experts have said. While Indian pharmaceutical companies could gain a competitive edge in the US market, the move may disrupt the medical device supply chain and drive-up costs for Indian firms exporting such products.

Big money was at stake since Esbriet, used to treat a serious lung disease called idiopathic pulmonary fibrosis, accounts for sales of $1 billion annually. To ensure high quality, medicines are procured from WHO Good manufacturing practice (GMP), Current Good Manufacturing Practice and CPSUs manufacturers for supplying to Pradhan Mantri Bhartiya Janaushadhi Kendras. Only after being certified by these laboratories, medicines are dispatched to C&F agents, Distributors and JAKs. Making quality medicines available at affordable prices for all, particularly the poor and disadvantaged, through exclusive outlets “Jan Aushadhi Medical Store”, so as to reduce out of pocket expenses in healthcare.

Hospira is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™ by developing, manufacturing, and marketing products that improve the productivity, safety, and efficacy of patient care. In February 2007, Hospira acquired MaynePharma Limited to become the world leader in specialty generic injectable pharmaceuticals. Dawaa Dost tied up with noted pharma companies to ensure that the best quality medicines are provided at the right price. In addition to its online presence spanning 19,000 pin codes across India, Dawaa Dost has 69 retail stores in 10 cities. Davaindia Generic Pharmacy a chain for generic pharmacy retail outlets across India established in 2017 with the aim to provide affordable and quality medicine to all and doing that have provided Happiness of Good Health for all.

For seller-fulfilled items from Fine Art category, the sellers need to be informed of the damage / defect within 10 days of delivery. This item is eligible for free replacement, within 10 days of delivery, in an unlikely event of damaged, defective or different/wrong item delivered to you. ZOTA will store the information provided by the visitors to meet the legal requirement or for the business/ market study purpose only and shall store the information until to mitigate the purpose aforementioned.

Careers

This absence allows manufacturers unchecked power to establish any MRP, potentially leading to arbitrary pricing regardless of the actual manufacturing cost of the medicine. The scheme further strengthens India’s pharmaceutical self-sufficiency and would ensure steady availability of vital medications. Enhanced bulk drug production capacity through the PLI scheme positions India to not just become a producer of finished formulations, but also a prominent supplier of raw materials. It helps Indian companies develop capabilities and technology for manufacturing of complex APIs. The projects under the scheme are facilitated and supported by the Department of Pharmaceuticals by hand holding and bringing about required regulatory streamlining across the Government departments.

According to the government data, the Indian pharmaceutical industry is worth approximately US$ 50 billion with over US$ 25 billion of the value coming from exports. Indian pharmaceutical industry is known for its generic medicines and low-cost vaccines globally. Transformed over the years as a vibrant sector, presently Indian Pharma ranks third in pharmaceutical production by volume. The Pharmaceutical industry in India is the third largest in the world in terms of volume and 14th largest in terms of value.

The government has set ambitious target to boost the medical devices industry in India, aiming to elevate it from its current US$ 11 billion valuation to US$ 50 billion by 2030. Presently, over 80% of the antiretroviral drugs used globally to combat AIDS (Acquired Immune Deficiency Syndrome) are supplied by Indian pharmaceutical firms. India is rightfully known as the “pharmacy of the world” due to the low cost and high quality of its medicines.

As the medicine’s patent expires, more pharmaceutical companies apply to get approval to sell the generic drug. Top 10 Generic Medicine Manufacturers in India – Generic Medicine PCD companies have become a major part of the pharmaceutical drug market. According to the survey, Indian generic manufacturers are particularly successful in the generics industry, with more businesses moving their production operations overseas to reduce costs. According to a recent analysis by the FDA, there are too many generic drug companies in India.

The mobile app provides customers an easy way to search for medications and order them directly from the store or website. Overall, Medkart’s commitment to providing access to quality generic medicines has been instrumental in improving the health outcomes of millions of people in India. Unlike branded medications, any medication marketed under its chemical name without advertising is also referred to as a generic drug. With the passing of the Patents Act in 1970, the Indian government started the domestic production of medicines by Indian businesses in the early 1960s. Dr Mandaviya said that “the PLI-I scheme of the Union Government identified 48 critical bulk drugs for manufacturing locally. The success of this inaugural scheme led the government to launch the Rs. 15,000 crore PLI-II scheme which envisaged to increase our cost competitiveness for medicines and medical products in the international market”.

India is counted amongst the largest supplier of generic drugs across the world and the pharmaceutical industry has helped in reducing the healthcare costs of many nations by exporting the medicines. As per the survey conducted in 2014 by the National Sample Survey Office (NSSO) on healthcare shows the staggering number of 82% in urban and 86% of the rural population not covered under any scheme of health expenditure support. Generic medicines are low in cost but as effective and safe as branded medicines. In India, it is being widely used, the PMBJP aims to spread more awareness among people.

In addition to this, innovative thinking to encourage private investments, and to explore newer funding avenues for high risk / long term projects have often been discussed. India is the largest provider of generic drugs globally and is known for its affordable vaccines and generic medications. The Indian Pharmaceutical industry is currently ranked third in pharmaceutical production by volume after evolving over time into a thriving industry growing at a CAGR of 9.43% since the past nine years. Generic drugs, over-the-counter medications, bulk drugs, vaccines, contract research & manufacturing, biosimilars, and biologics are some of the major segments of the Indian pharma industry.

Jai Jawan, Jai Kisan, Jai Vigyaan aur Jai Anusandhan. There is immense ground to be covered by India in R&D in various sectors. NITI Aayog has flagged India’s lagging position vis-à-vis other countries in this regard. With an eye on the ample opportunities that can be explored and captured, the Parliament recently approved the Anusandhan National Research Foundation (NRF) Bill, 2023, which provides for establishing the Anusandhan National Research Foundation (NRF). Pharmacists are knowledgeable about drugs and can easily help you identify whether a medicine is generic or brand-name based on its name and packaging. If you ever have any questions about your prescription medications, it is always best to consult your pharmacist before taking action on your behalf. With coronavirus cases increasing, several more of the big India-based healthcare firms which make much of the world’s pharmaceuticals are expected to launch competing versions of remdesivir, the only major treatment so far approved for COVID-19.

He highlighted the efforts of the administration in enhancing self-reliance, innovation and infrastructure, including both physical and digital as displays of such a vision. Employees based out of 50+ offices all over the world working towards one mission – Enriching lives globally. We are creating centers of excellence in dermatology, oncology and respiratory therapy.

The company develops pharmaceuticals in different formulations, including liquids, ointments, tablets, capsules, injectables, granules and powder. These products cater to the treatment of gastroenterological, gynaecological, urological and neurological diseases, as well as diabetes, pain and infections. Headquartered in Gurgaon, Fortis Healthcare Limited is an IHH Healthcare Berhad subsidiary and is a prominent integrated healthcare services provider in India. With 28 healthcare facilities and over 400 diagnostics centres across India, the United Arab Emirates (UAE), Sri Lanka and Nepal, it is among the country’s largest healthcare organisations.

Inexpensive medicines are one of the most important factors for reducing healthcare cost. Brand-name drugs often come in unique packaging (that is easy to identify) which helps recognize them easily on store shelves or online. In contrast, generic drugs are sold in plain packaging without special logos or design elements that make them stand out from other products. Zota Healthcare Limited has evolved from a humble beginning in 2000 to a well-established and acclaimed NSE listed pharmaceutical company in India.

In developing countries like India, government bodies and other regulatory bodies have pushed manufacturers to launch effective generic drugs supporting pharma market growth. The introduction of 3-D printing technology helps in manufacturing generic medicines with varying release dates and tastes and has pushed the share of generic drugs in pharma industry. Hailed as the “pharmacy of the world”, the booming pharmaceutical industry of India is a leading source of cutting edge innovation especially when it comes to providing life-saving medicines at affordable prices to people.

To know the generic name of the medicine you are looking for, you can also use a free web service such as This website has a database of over 1 lakh medicines. Before investing, investors must conduct independent research and not solely rely on the information provided here. This will allow investors to make appropriate investment decisions based on their financial goals, investment objectives and risk tolerance.